Skip to main content

Day: August 1, 2025

BW Energy: Second quarter and first half 2025 results 

BW Energy delivered strong operational performance in the first half of 2025, driven by high production uptime, competitive cost levels, and a solid safety record with zero lost time incidents. The Company’s project portfolio continues to advance, with final investment decisions taken on both the Maromba development and the Golfinho Boost project. In addition, a substantial oil discovery was made at the Bourdon prospect in the Dussafu area, further expanding BW Energy’s resource base. Backed by strong cash generation and a resilient financial structure, BW Energy is well placed to drive growth and create long-term shareholder value.  HIGHLIGHTS  Strong operational performance H1 2025 net production of 6.2 (4.6) million barrels, equal to 34.2 (25.4) kbopd  Operating cost1 of USD 18.3 (26.2) per barrel and zero lost time incidents ...

Continue reading

Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) further to its news release of July 8th, 2025, the Company provides certain updates in respect of its technology licensing agreement dated July 7th, 2025 (the “Technology Licensing Agreement”), amongst the Company and Matthew J. Mason (the “Lessor”). The Lessor holds the exclusive license to certain proprietary technology and know-how that can be used to assist in area prioritization selection for the purposes of exploration for minerals (the “Technology”), which was developed by an arm’s length Ph.D. geologist (the “Licensor”). In particular, the Lessor obtained its license in the Technology...

Continue reading

Diplomatic Trade Ltd, Thomas J. Kent Jr. the Kent Family Office, and Kent Global LLC Stake Acquisition in Turkish Pharma Firm, Target $300M UAE Biopharma Venture

Cross-border biopharma venture targets $300M IPO valuation and UAE facility launch by Q3 2025Thomas J. Kent Jr. DUBAI, United Arab Emirates, July 31, 2025 (GLOBE NEWSWIRE) — Diplomatic Trade Ltd and Kent Global Support Strategic Stake in Turkish Pharma Group, Plan $300M UAE Biopharma Initiative Cross-border biopharma venture targets UAE facility launch in Q3 2025 and public listing by year-end Diplomatic Trade Ltd, a cross-border trade and investment firm with offices in New York and Dubai, and its private equity arm, Diplomatic Trade Capital Group, have signed an MOU to acquire a 49% stake in Turkish pharmaceutical manufacturer Farmakim ilaç Kimya Gida Ürünleri Üretim San ve Dis Tie A.S. The transaction was supported by U.S.-based Kent Family Office LLC and its affiliated investment firm, Kent Global LLC, led by financier Thomas...

Continue reading

The Ether Machine Marks Ethereum’s 10th Birthday with Major ETH Treasury Purchase

New York, NY, July 31, 2025 (GLOBE NEWSWIRE) — The Ether Machine, the ether generation company, announced yesterday that The Ether Reserve LLC has purchased nearly 15,000 ETH at $3,809.97 USD for a total of $56,900,000.01 USD as part of The Ether Machine’s long-term accumulation strategy. This brings total ETH purchased and committed to 334,757 with up to $407,000,000 of USD remaining for additional ETH purchases. Timed to coincide with Ethereum’s 10-year anniversary, the purchase marks the beginning of The Ether Machine’s treasury deployment, and reflects a deep conviction in ETH as the most important asset of the decentralized internet and its mission to build a long-term, institutional-grade ETH treasury. “We couldn’t imagine a better way to commemorate Ethereum’s 10th birthday than by deepening our commitment to ether,” said...

Continue reading

XPENG Announces Vehicle Delivery Results for July 2025

Cumulative total deliveries surpassed 800,000 units Set a new monthly record of 36,717 units in July, representing 229% YoY growth Marked the ninth straight month exceeding 30,000 deliveriesGUANGZHOU, China, July 31, 2025 (GLOBE NEWSWIRE) — XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today announced its vehicle delivery results for July 2025. XPENG achieved a new record monthly deliveries of 36,717 Smart EVs in July, representing a year-over-year increase of 229% and marking the Company’s ninth consecutive month surpassing 30,000 deliveries. This brings the Company’s cumulative total deliveries to over 800,000 units as of July 2025. In the first seven months of 2025, XPENG delivered 233,906 Smart EVs, a 270% increase compared with the same period...

Continue reading

Silexion Therapeutics Announces Exercise of Warrants for $1.8 Million Gross Proceeds

Cayman Islands, July 31, 2025 (GLOBE NEWSWIRE) — Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech company developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 152,106 of the Company’s ordinary shares originally issued in January 2025 at a reduced exercise price of $11.57 per share. The ordinary shares issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (File No. 333-282932) and an effective resale registration statement on Form S-1 (No. 333-284873). The gross proceeds to the Company from the exercise of the warrants are expected to be approximately...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.